Kornitzer Capital Management Inc Acadia Pharmaceuticals Inc Transaction History

Kornitzer Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$25.02 - $54.99 $2.73 Million - $5.99 Million	-108,935 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$41.04 - $56.79 $54,378 - $75,246	-1,325 Reduced 1.2%	108,935 $5.82 Million
Q3 2020 Oct 30, 2020	SELL	$36.42 - $57.0 $7.59 Million - $11.9 Million	-208,312 Reduced 65.39%	110,260 $4.55 Million
Q2 2020 Aug 03, 2020	BUY	$39.26 - $52.73 $8.08 Million - $10.8 Million	205,722 Added 182.3%	318,572 $15.4 Million
Q1 2020 Apr 30, 2020	BUY	$31.65 - $46.87 $3.57 Million - $5.29 Million	112,850 New	112,850 $4.77 Million

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.71B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.